Royal Bank of Canada’s Monopar Therapeutics MNPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1K | Sell |
19
-186
| -91% | -$9.79K | ﹤0.01% | 6517 |
|
2025
Q1 | $7K | Buy |
+205
| New | +$7K | ﹤0.01% | 5880 |
|
2024
Q2 | – | Sell |
-20
| Closed | – | – | 6869 |
|
2024
Q1 | $0 | Buy |
+20
| New | – | ﹤0.01% | 6798 |
|
2023
Q2 | – | Sell |
-1,000
| Closed | -$7K | – | 6974 |
|
2023
Q1 | $7K | Buy |
+1,000
| New | +$7K | ﹤0.01% | 6071 |
|
2022
Q3 | – | Sell |
-823
| Closed | -$9K | – | 7140 |
|
2022
Q2 | $9K | Hold |
823
| – | – | ﹤0.01% | 5963 |
|
2022
Q1 | $10K | Hold |
823
| – | – | ﹤0.01% | 6459 |
|
2021
Q4 | $13K | Hold |
823
| – | – | ﹤0.01% | 6440 |
|
2021
Q3 | $20K | Sell |
823
-203
| -20% | -$4.93K | ﹤0.01% | 6183 |
|
2021
Q2 | $30K | Sell |
1,026
-800
| -44% | -$23.4K | ﹤0.01% | 5844 |
|
2021
Q1 | $57K | Buy |
+1,826
| New | +$57K | ﹤0.01% | 5308 |
|